Trial intelligence / Profile preview

Danaparoid vs heparin plus low-dose aspirin in obstetric antiphospholipid syndrome

jRCTs041180093Completed

Start
Jan 2006
Countries
1
01

Overview

Randomised trial of danaparoid sodium in antiphospholipid syndrome (APS) (2 arms). Primary endpoint: Live birth rate. Started Jan 2006; status: completed.

02

Drugs

danaparoid sodium
03

Conditions

antiphospholipid syndrome (APS)

Beyond the preview

Go deeper on jRCTs041180093.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs041180093.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call